[YTL] QoQ Annualized Quarter Result on 31-Dec-2021 [#2]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
24-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2022
Quarter
31-Dec-2021 [#2]
Profit Trend
QoQ- 14.65%
YoY- 1287.71%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 25,954,636 24,161,103 24,115,893 23,832,540 20,186,388 17,356,196 17,320,428 30.91%
PBT 815,952 1,558,723 1,846,590 934,648 1,301,696 638,523 704,482 10.27%
Tax -321,432 -385,036 -419,989 -452,086 -589,676 -966,004 -401,005 -13.69%
NP 494,520 1,173,687 1,426,601 482,562 712,020 -327,481 303,477 38.43%
-
NP to SH 146,484 530,546 695,826 482,562 420,888 -368,688 53,089 96.60%
-
Tax Rate 39.39% 24.70% 22.74% 48.37% 45.30% 151.29% 56.92% -
Total Cost 25,460,116 22,987,416 22,689,292 23,349,978 19,474,368 17,683,677 17,016,950 30.78%
-
Net Worth 12,718,339 12,827,982 12,608 11,841,215 12,279,778 12,353,831 12,653,038 0.34%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div - 328,922 - - - 266,246 - -
Div Payout % - 62.00% - - - 0.00% - -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 12,718,339 12,827,982 12,608 11,841,215 12,279,778 12,353,831 12,653,038 0.34%
NOSH 11,022,762 11,022,762 11,022,762 11,022,762 11,022,762 11,022,762 11,022,762 0.00%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 1.91% 4.86% 5.92% 2.02% 3.53% -1.89% 1.75% -
ROE 1.15% 4.14% 5,518.62% 4.08% 3.43% -2.98% 0.42% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 236.72 220.37 219,953.48 217.37 184.11 162.97 162.90 28.26%
EPS 1.32 4.84 6.35 1.96 3.84 -3.47 0.49 93.48%
DPS 0.00 3.00 0.00 0.00 0.00 2.50 0.00 -
NAPS 1.16 1.17 1.15 1.08 1.12 1.16 1.19 -1.68%
Adjusted Per Share Value based on latest NOSH - 11,022,762
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 233.84 217.68 217.27 214.72 181.87 156.37 156.05 30.91%
EPS 1.32 4.78 6.27 4.35 3.79 -3.32 0.48 96.16%
DPS 0.00 2.96 0.00 0.00 0.00 2.40 0.00 -
NAPS 1.1459 1.1558 0.0011 1.0668 1.1064 1.113 1.14 0.34%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 0.58 0.585 0.59 0.58 0.61 0.655 0.675 -
P/RPS 0.25 0.27 0.00 0.27 0.33 0.40 0.41 -28.07%
P/EPS 43.41 12.09 0.01 13.18 15.89 -18.92 135.19 -53.07%
EY 2.30 8.27 10,756.64 7.59 6.29 -5.29 0.74 112.82%
DY 0.00 5.13 0.00 0.00 0.00 3.82 0.00 -
P/NAPS 0.50 0.50 0.51 0.54 0.54 0.56 0.57 -8.35%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 24/11/22 25/08/22 26/05/22 24/02/22 25/11/21 08/09/21 28/05/21 -
Price 0.55 0.57 0.595 0.545 0.585 0.665 0.68 -
P/RPS 0.23 0.26 0.00 0.25 0.32 0.41 0.42 -33.04%
P/EPS 41.17 11.78 0.01 12.38 15.24 -19.21 136.19 -54.92%
EY 2.43 8.49 10,666.25 8.08 6.56 -5.21 0.73 122.77%
DY 0.00 5.26 0.00 0.00 0.00 3.76 0.00 -
P/NAPS 0.47 0.49 0.52 0.50 0.52 0.57 0.57 -12.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment